当前位置: X-MOL 学术J. Urol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy.
The Journal of Urology ( IF 6.6 ) Pub Date : 2024-02-14 , DOI: 10.1097/ju.0000000000003891
Todd M. Morgan 1 , Stephen A. Boorjian 2 , Mark K. Buyyounouski 3 , Brian F. Chapin 4 , David Y. T. Chen 5 , Heather H. Cheng 6 , Roger Chou 7 , Heather A. Jacene 6 , Sophia C. Kamran 8 , Sennett K. Kim 9 , Erin Kirkby 9 , Amy N. Luckenbaugh 10 , Ben J. Nathanson , Yaw A. Nyame 11 , Edwin M. Posadas 12 , Phuoc T. Tran 13 , Ronald C. Chen 14
Affiliation  

The summary presented herein covers recommendations on salvage therapy for recurrent prostate cancer intended to facilitate care decisions and aid clinicians in caring for patients who have experienced a recurrence following prior treatment with curative intent. This is Part II of a 3-part series focusing on treatment delivery for non-metastatic biochemical recurrence (BCR) after primary radical prostatectomy (RP). Please refer to Part I for discussion of treatment decision-making and Part III for discussion of evaluation and management of recurrence after radiotherapy (RT) and focal therapy, regional recurrence, and oligometastasis.

中文翻译:

前列腺癌的挽救治疗:AUA/ASTRO/SUO 指南第二部分:初次根治性前列腺切除术后非转移性生化复发的治疗。

本文提出的总结涵盖了复发性前列腺癌挽救治疗的建议,旨在促进护理决策并帮助临床医生护理在先前以治愈为目的的治疗后经历复发的患者。这是三部分系列的第二部分,重点关注初次根治性前列腺切除术 (RP) 后非转移性生化复发 (BCR) 的治疗。请参阅第一部分讨论治疗决策,第三部分讨论放疗(RT)和局部治疗后复发、区域复发和寡转移的评估和管理。
更新日期:2024-02-14
down
wechat
bug